Hjem › Larynxcancer › Missouri › St. Louis
Kliniske studier for Larynxcancer i St. Louis, MO
7 studier for Larynxcancer søker deltakere på steder i og rundt St. Louis (innen ca. 30 miles). Åpne et studie for å se hvem som kan delta og hvordan du kontakter studieteamet.
Offisiell studietekst (engelsk)
Rekrutterer til et studie her? Få det fremtredende øverst på siden – $99 i 30 dager →
Testing the Addition of Chemotherapy or Chemo-Immunotherapy to the Usual Surgery for Advanced Head and Neck Cancer
RekruttererFase 2
- Washington University School of Medicine, St Louis
- Siteman Cancer Center-South County, St Louis
- Siteman Cancer Center at Christian Hospital, St Louis
- og 2 flere
Testing the Addition of Anti-Cancer Drug, Cetuximab, to Standard of Care Treatment (Pembrolizumab) for Returning or Spreading Head and Neck Cancer After Previous Treatment
RekruttererFase 3
- Washington University School of Medicine, St Louis
- Mercy Hospital South, St Louis
- Siteman Cancer Center-South County, St Louis
- og 4 flere
BiCaZO: A Study Combining Two Immunotherapies (Cabozantinib and Nivolumab) to Treat Patients With Advanced Melanoma or Squamous Cell Head and Neck Cancer, an immunoMATCH Pilot Study
RekruttererFase 2
- Washington University School of Medicine, St Louis
- Mercy Hospital South, St Louis
- Siteman Cancer Center-South County, St Louis
- og 4 flere
Radiation Therapy With or Without Cisplatin in Treating Patients With Stage III-IVA Squamous Cell Carcinoma of the Head and Neck Who Have Undergone Surgery
RekruttererFase 2
- Mercy Infusion Center - Chippewa, St Louis
- Mercy Hospital South, St Louis
- Missouri Baptist Medical Center, St Louis
- og 4 flere
Comparing Radiation Plus Cetuximab to Radiation Plus Chemotherapy in People With Head and Neck Cancer Who Cannot Receive Cisplatin
RekruttererFase 3
- Cancer Care Center of O'Fallon, O'Fallon · 16 mi unna
- HSHS Saint Elizabeth's Hospital, O'Fallon · 16 mi unna
Multi-Site Trial of Navigation vs Treatment as Usual to Improve Initiation of Timely Adjuvant Therapy
Rekrutterer
- Washington University in St. Louis, St Louis
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
RekruttererObservasjonsstudie
- Massive Bio SYNERGY-AI site, St Louis
Larynxcancer-studier i andre byer
- Atlanta, GA8 studier
- Chicago, IL8 studier
- Milwaukee, WI8 studier
- Kansas City, MO7 studier
- Portland, OR7 studier
- Baltimore, MD6 studier
- Cincinnati, OH6 studier
- Edison, NJ6 studier
- Richmond, VA6 studier
- Durham, NC6 studier
- Pittsburgh, PA6 studier
- Overland Park, KS5 studier
Andre studier i St. Louis
- Ikke-småcellet lungekreft73 studier
- Brystkreft64 studier
- Metastatisk kreft54 studier
- Kolorektal kreft50 studier
- Kreft (alle typer)46 studier
- Prostatakreft46 studier
- Lungekreft39 studier
- Eggstokkreft38 studier
- Pankreaskreft33 studier
- Endometriekreft29 studier
- Plateepitelcancer i hode og hals28 studier
- Hjertesvikt26 studier
Fra ClinicalTrials.gov, data hentet 6. okt. 2026. Hver studie setter sine egne kvalifikasjonskrav; studieteamet avgjør hvem som kan delta.